WO1998044959A1 - Composition desodorisante - Google Patents

Composition desodorisante Download PDF

Info

Publication number
WO1998044959A1
WO1998044959A1 PCT/JP1997/001167 JP9701167W WO9844959A1 WO 1998044959 A1 WO1998044959 A1 WO 1998044959A1 JP 9701167 W JP9701167 W JP 9701167W WO 9844959 A1 WO9844959 A1 WO 9844959A1
Authority
WO
WIPO (PCT)
Prior art keywords
component
deodorant
dihydroxybenzene
benzoquinone
naphthoquinone
Prior art date
Application number
PCT/JP1997/001167
Other languages
English (en)
Japanese (ja)
Inventor
Yasuo Fujimoto
Tadashi Imai
Tadao Hamaya
Original Assignee
Ricom Corporation
Ricom Shoji Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ricom Corporation, Ricom Shoji Corp. filed Critical Ricom Corporation
Priority to PCT/JP1997/001167 priority Critical patent/WO1998044959A1/fr
Priority to AU21788/97A priority patent/AU2178897A/en
Priority to TW086104957A priority patent/TW371630B/zh
Publication of WO1998044959A1 publication Critical patent/WO1998044959A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/01—Deodorant compositions

Definitions

  • the present invention relates to a deodorant. More specifically, the present invention relates to metabolism in the body of humans and animals, indoors, in cars, refrigerators, toilets, livestock farms, pig farms, poultry farms, fish farms, and other odors.
  • the present invention relates to a deodorant that can effectively remove or reduce malodors and off-odors derived from components having, for example, amines, mercaptans, and fatty acids.
  • pineapple As a deodorant that can effectively remove or reduce bad odors and odors generated in the metabolism of humans and animals, toilets, livestock farms, and other environments, pineapple is water or a hydrophilic solvent.
  • the mushroom extract is a mixture containing many types of components, and no component having a deodorizing effect has been identified. In other words, this extract is expected to contain components that have no deodorizing effect at all, and it is necessary to use a relatively large amount to obtain an effective deodorizing effect.
  • problems such as contamination of the wall surface or precipitation of components that do not have a deodorizing effect, resulting in deterioration of the storage stability of the product.
  • An object of the present invention is to provide a deodorant which does not have such a problem and has an excellent deodorizing effect, particularly, a spatial deodorizing effect.
  • the present invention provides a deodorant containing, as an active ingredient, at least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof.
  • the present invention also provides a deodorant containing, as an active ingredient, an extract obtained by extracting an acidic aqueous extract of mushrooms with an organic solvent insoluble or slightly soluble in water.
  • the present invention provides a deodorant containing, as active ingredients, at least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof, and an acidic aqueous extract of mushrooms. It is provided.
  • the present invention also provides an extract obtained by extracting an acidic aqueous extract of mushrooms with an organic solvent insoluble or slightly soluble in water; and a deodorant containing an acidic aqueous extract of mushrooms as an effective component. Is provided.
  • the present invention further relates to at least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof; wherein the acidic aqueous extract of mushrooms is insoluble or slightly soluble in water.
  • the present invention provides a deodorant comprising: an extract obtained by extraction with an organic solvent; and an acidic aqueous extract of mushrooms.
  • At least one compound selected from the group consisting of dihydroxybenzene, benzoquinone, dihydroxynaphthalene, naphthoquinone and derivatives thereof, which is an active ingredient of the deodorant of the present invention (hereinafter, these compounds are referred to as “component A”). ) Will be described.
  • Preferred compounds as the A component of the present invention are 1,4-dihydroxybenzene, 1,4-benzoquinone, 1,4-dihydroxynaphthylene, 1,4-naphthoquinone, 1,2-dihydroxybenzene, and 1,2-bene.
  • R 1 to R 4 are each independently a hydrogen atom, a linear or branched, saturated or unsaturated, substituted or unsubstituted hydrocarbon group, and An alkyl group, a carboxyalkyl group, a carboxyalkenyl group, a carboxyl group, an aryl group having 6 to 20 carbon atoms, and R 1 and R 2 are reduced in cooperation with each other.
  • 'It may form a ring.
  • R 5 to R 8 are each independently a hydrogen atom, a linear or branched, saturated or unsaturated, substituted or unsubstituted hydrocarbon group, and An alkyl group, a carboxyalkyl group, a carboxyalkenyl group, a carboxyl group, or an aryl group having 6 to 20 carbon atoms, and R 5 and R 6 may together form a condensed benzene ring
  • R 5 and R 6 may together form a condensed benzene ring
  • preferred are 1,4-dihydroxybenzene, 1,4-dihydroxynaphthylene and derivatives thereof, and particularly preferred are the compounds represented by the general formula (3) It is a compound represented by these.
  • the deodorant of the present invention may be composed of only the active ingredient A, but it is used in a form in which a predetermined amount of the ingredient A is contained in foods, oral compositions, pharmaceuticals, feeds, and the like. You can also. Further, the deodorant of the present invention is used in the form of an aerosol composition. You can also. Commercially available A component, which is an active ingredient of the deodorant of the present invention, may be used as it is, but A component obtained by extracting an acidic aqueous extract of mushrooms with an organic solvent insoluble or slightly soluble in water. (Hereinafter, this extract may be referred to as "component B"). The present inventors have further studied the deodorant active ingredient contained in the mushroom extract, and as a result, have found that the deodorant active ingredient is the A component, and completed the present invention. It is a thing.
  • the component A which is an active ingredient of the deodorant of the present invention, includes known substances. Therefore, a commercially available component A can be used as it is as an active ingredient of the deodorant of the present invention.
  • the extract obtained by extracting the acidic aqueous extract of mushrooms with an organic solvent insoluble or slightly soluble in water contains a large amount of the A component. This extract may be used as it is, or it may be used after further purification and isolation of component A.
  • a 0.05 to 10% by weight aqueous solution of an acid for example, an organic acid such as malic acid, citric acid, or acetic acid, or an inorganic acid such as hydrochloric acid
  • an acid for example, an organic acid such as malic acid, citric acid, or acetic acid, or an inorganic acid such as hydrochloric acid
  • the acidic water extract (hereinafter sometimes referred to as “component C”) is preferably further concentrated 2 to 50 times, more preferably 10 to 20 times, and then concentrated.
  • an extract (component B) containing a large amount of component A (for example, 2.5 to 25% by weight) can be obtained.
  • Purification by separation and purification means such as chromatography yields pure A component, ie, 1,4-dihydroxybenzene.
  • the present invention relates to an extract (C component) containing a large amount (for example, 0.01 to 5% by weight) of the A component thus obtained, and a further large amount of the A component obtained by purifying the C component. (For example, 2.5 to 25% by weight) containing an extract (B component) or an A component obtained by further refining the B component as an active ingredient.
  • the deodorant of the present invention may be composed of 100% by weight of the component A.
  • the deodorant containing components other than the component A is convenient in use and economically. Is also advantageous.
  • the content of the component A in the deodorant of the present invention in the case of using the component B or the component C, it means the total amount including the component A included in these components.
  • the food containing the deodorant of the present invention is not particularly limited.
  • candy, chewing gum, confectionery, bread, pickles, seasonings, miso, porridge, drinks, jelly, soup, gyoza, health food examples include wine and shochu.
  • the content of the A component in the food is usually from 0.0005 to 50% by weight, preferably from 0.005 to 0.5% by weight, and more preferably from 0.005 to 0.5% by weight. 0.05% by weight.
  • the oral composition containing the deodorant of the present invention is not particularly limited, and examples thereof include toothpaste and mouthwash compositions.
  • the content of the component A in the oral composition is usually from 0.0005 to 50% by weight, preferably from 0.005 to 0.5% by weight, more preferably from 0.5 to 0.5% by weight. It is 0.05 to 0.05% by weight.
  • the drug containing the deodorant of the present invention is not particularly limited, and examples thereof include a gastrointestinal drug, a bimin drug and the like.
  • the content of the component A in the drug is usually 0.0005 to 50% by weight, preferably 0.05 to 0.5% by weight, more preferably 0.05 to 0.5% by weight. ⁇ 0.05% by weight.
  • the feed containing the deodorant of the present invention is not particularly limited. Examples thereof include livestock such as cattle, pigs, horses, and sheep, poultry such as chickens, quail, goose, turkey, duck, ostrich, etc. Animal feed (including fish, etc.) raised in pet animals such as small birds, zoos, aquariums, fish farms, etc., and other animal feeds.
  • the content of the component A in such feed is usually 0.0005 to 50% by weight, preferably 0.005 to 0.5% by weight, and more preferably 0.05 to 0.5% by weight. 0.5-0.05% by weight.
  • the deodorant of the present invention can be used alone as the component A, the component B, a combination of the components A and B, a combination of the components A and C, a combination of the components B and C, A component, B component and C component can also be used in combination.
  • the active ingredient can be used as it is, or can be added to various carriers such as foods, oral compositions, pharmaceuticals, feeds and the like, and used in the form of solids, liquids, powders and the like. Further, it can be used in the form of an aerosol composition.
  • the aerosol composition may contain only the active ingredient of the deodorant of the present invention as an active ingredient, or may contain other components that do not inhibit the deodorant effect of the deodorant of the present invention. .
  • the content of the component A in the aerosol composition is usually from 0.0005 to 5% by weight, preferably from 0.005 to 0.5% by weight, and more preferably from 0.005 to 0.5% by weight. 00.05% by weight.
  • the oral deodorant of the present invention can remove or reduce malodors such as bad odors and bad odors generated by the metabolism of foods or foods by ingesting an appropriate amount orally.
  • Oral ingestion of the deodorant of the present invention may be usually before, during, or after ingestion of food, but is preferably before or ingestion of food.
  • the oral intake varies depending on the degree of bad breath and body odor, and is not particularly limited. However, as the A component, it is usually 0.05 to 5 Omg, preferably 0.05 to 5 mg per day for an adult. . In order to use the deodorant of the present invention for removing or reducing the malodor and off-flavor of the environment, it is preferable to add the deodorant of the present invention to the feed of the target animal.
  • the environment where components with bad odors and off-flavors may be generated (eg, indoors, cars, refrigerators, toilets, livestock farms, pig farms, poultry farms, fish farming) It is also effective to spray the deodorant of the present invention in the field or other places).
  • Application rate varies depending on the degree of bad smell 'off-flavor, usually, per lm 2 or lm 3, 0 as the A component. 0 0 0 5 to 1 0 g, preferably 0.0 0 5 about 1 g is appropriate It is.
  • the deodorant active ingredient of the present invention is the A component in the metabolite of matsushroom, and thus, a deodorant effect can be obtained.
  • hydroquinone of component A is oxidized to benzoquinone, addition of mercapones and adsorption of ammonia and amines occur, and the deodorizing effect is exhibited.
  • the active ingredient A of the present invention is non-toxic or low-toxic.
  • the LD 50 value of 1,4-dihydroxybenzene after oral administration to rats is 32 Omg / kg [Woodard, Fed. Proc. , 8, 348 (1949)].
  • the present invention will be described more specifically with reference to Examples.
  • TLC thin layer chromatography
  • Example 1 25 mg of the A component (1,4-dihydroxybenzene) obtained from 4.69 g of the ethyl acetate extract was diluted 480-fold with purified water, and further diluted with purified water. The deodorizing effect on methyl mercaptan was examined using the liquid diluted 50-fold with the following test method. At the same time, a diluent of a commercially available 1,4-dihydroxybenzene (manufactured by Tokyo Chemical Industry Co., Ltd.) was prepared in the same manner, and its deodorizing effect was similarly examined.
  • 1,4-dihydroxybenzene manufactured by Tokyo Chemical Industry Co., Ltd.
  • Example 1 Using the A component (1,4-dihydroxybenzene), the B component and the C component obtained in Example 1, a chewing gum was produced with the following composition.
  • the numbers indicate the number of g in 100 g of chewing gum.
  • Composition 1 Composition 2 Composition 3 No. Latinit 64.0 64.7 64.7 Gum base 25.0 25.0 25.0
  • Example 1 Using the A component (1,4 dihydroxybenzene), the B component and the C component obtained in Example 1, a candy was produced with the following composition. The number indicates the number of g in 100 g of the candy.
  • Composition 1 Composition 2
  • Composition 3 Granulated sugar 60.0 61.0 61.0
  • Example 1 Using A component (1,4-dihydroxybenzene), B component and C component obtained in Example 1, a drink was produced with the following composition. The number indicates the number of g in 100 g of drink.
  • Composition 1 Composition 2
  • Composition 3 Liquid sugar 10.7 10.7 10.7 Sugar 3.0 3.0 3.0
  • Malic acid 0.1 0.1 0.1 0.1
  • Example 2 Using the A component (1,4-dihydroxybenzene), the B component, and the C component obtained in Example 1, an aerosol composition having the following composition was produced.
  • the numbers indicate the number of g in 100 g of the aerosol composition.
  • Composition 1 Composition 2
  • Composition 3 Ethanol 99.16 99.75 99.75 Ethyl paraben 0.12 0.12 0.12 Propyl paraben 0.06 0.06 0.06 Butyl paraben 0.06 0.06 0.06 A component 0.0000625 B component 0.00125
  • component A, component B, a combination of components A and B, or a combination of component C and component C Can be used, but contains components other than the deodorant active ingredient, does not contain component B or C, especially does not contain component C, that is, contains only component A as an active ingredient are preferred.
  • component C has stickiness and peculiar odor, and when used in aerosols, there is a problem that the odor is worrisome. This is because there is no odor or odor, and the deodorizing effect is also quick.
  • the deodorant of the present invention when used as an oral deodorant for foods, vaginal compositions, pharmaceuticals, feeds, pet foods, etc., A component, B component, a combination of A component and B component, or Can be used in combination with component C, but deodorant includes components other than active components, components containing components C and B, especially those containing component C, that is, a combination of component C and component A
  • deodorant includes components other than active components, components containing components C and B, especially those containing component C, that is, a combination of component C and component A
  • the combination of the C component and the B component, the combination of the C component, the B component and the A component, and the combination of the B component and the A component are preferable.
  • the active ingredient A When used in vivo to remove bad odors such as bad breath, body odor, and fecal odor, the active ingredient A alone may be used.However, in order to obtain the effect of improving diarrhea and constipation, etc. It is better to use C and B components together. That is, when used for the purpose of deodorization in a living body, the C or B component obtained by highly concentrating a mushroom acidic water extract is preferable, and the A solution is added to the concentrated solution (C or B component). By using this, the intestinal deodorization and prevention of diarrhea and constipation, and the improvement of the entire intestinal environment, such as the effect of multiplying useful intestinal bacteria, are achieved.
  • the component contains a component that acts as a certain catalyst to improve the intestinal deodorizing effect in cooperation with the component A.
  • the deodorant of the present invention can be used in combination with a material that has a favorable effect on the intestinal environment, such as oligosaccharides, dietary fiber, and lactic acid bacteria.
  • a material that has a favorable effect on the intestinal environment such as oligosaccharides, dietary fiber, and lactic acid bacteria.
  • the following test examples show test examples conducted using feed that combines component A and component C or component B.
  • aqueous solution obtained by dissolving 200 g of component A (1,4-dihydroxybenzene) and 1.6 kg of dextrin in 2 kg of a concentrate (component C) prepared from 1 O kg of mushrooms according to the method of Example 1 kg, and spray-dried to obtain 2 kg of the feed powder of the present invention.
  • This feed powder was administered to Holstein beef cattle once a day for 10 days at 10 Omg, and the stool odor and stool flatness were observed.
  • Table 3 shows an overview of the test cows. To three test groups, 100 mg of feed powder was dissolved in 500 cc of warm water and administered. Three control groups received only warm water.
  • Fecal odor was evaluated by sensory tests, and the deodorizing effect was evaluated in the following three stages.
  • the condition of the stool was visually observed and evaluated in the following three stages.
  • G male 25 years old
  • H female 26 years old
  • I male 41 years old
  • the fecal odor suppression and intestinal environment were examined for 3 days before the start of ingestion and 11 days after the start, for a total of 14 days.
  • Fecal odor was evaluated by sensory tests, and the deodorizing effect was evaluated in the following three stages.
  • the intestinal environment (constipation, diarrhea, etc.) was evaluated in the following three stages by self-examination by panelists.
  • the deodorant of the present invention contains the A component and / or the B component as an active ingredient, and has a more concentrated active ingredient compared to a conventional deodorant composed of mushroom extract (C component). It can effectively deodorize various foods, especially chewing gum, candy, and other foods that are difficult to ingest in large amounts by simply adding a small amount.
  • the deodorant of the present invention containing only the A component as an active ingredient is an unnecessary component other than the deodorant component, and does not contain a component that causes precipitation peculiar to the matsushroom extract. It can prevent the generation of sediment even when applied to other products, and can be widely used as a variety of products, especially as a space deodorant.

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Cosmetics (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne, d'une part, une composition désodorisante contenant, en tant que composant principal, au moins un composé sélectionné à partir du groupe contenant du dihydroxybenzène, de la benzoquinone, du dihydroxynaphthalène, de la naphthaquinone et des dérivés de ces composés; et d'autre part, des aliments, des préparations à avaler, des médicaments et de la nourriture contenant ladite composition désodorisante.
PCT/JP1997/001167 1997-04-04 1997-04-04 Composition desodorisante WO1998044959A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PCT/JP1997/001167 WO1998044959A1 (fr) 1997-04-04 1997-04-04 Composition desodorisante
AU21788/97A AU2178897A (en) 1997-04-04 1997-04-04 Deodorant
TW086104957A TW371630B (en) 1997-04-04 1997-04-17 Deodorizer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1997/001167 WO1998044959A1 (fr) 1997-04-04 1997-04-04 Composition desodorisante

Publications (1)

Publication Number Publication Date
WO1998044959A1 true WO1998044959A1 (fr) 1998-10-15

Family

ID=14180360

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1997/001167 WO1998044959A1 (fr) 1997-04-04 1997-04-04 Composition desodorisante

Country Status (3)

Country Link
AU (1) AU2178897A (fr)
TW (1) TW371630B (fr)
WO (1) WO1998044959A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047045A1 (fr) * 1999-02-13 2000-08-17 Zylepsis Limited Composes et compositions de conservation
JP2009161502A (ja) * 2008-01-10 2009-07-23 Rikomu:Kk 腸内菌叢改善剤及び食品
WO2013083585A1 (fr) 2011-12-06 2013-06-13 Unilever N.V. Composition antimicrobienne
WO2013092427A2 (fr) 2011-12-22 2013-06-27 Unilever N.V. Procédé et composition antimicrobiens
US8945596B2 (en) 2008-10-20 2015-02-03 Conopco, Inc. Antimicrobial composition
US9132103B2 (en) 2009-09-24 2015-09-15 Conopco, Inc. Disinfecting agent comprising eugenol, terpineol and thymol
US9408870B2 (en) 2010-12-07 2016-08-09 Conopco, Inc. Oral care composition
US9693941B2 (en) 2011-11-03 2017-07-04 Conopco, Inc. Liquid personal wash composition

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4833035A (fr) * 1971-08-27 1973-05-07
JPS5036649A (fr) * 1973-08-06 1975-04-05
JPS6368172A (ja) * 1986-09-11 1988-03-28 松下電工株式会社 消臭剤
JPS6434368A (en) * 1987-07-31 1989-02-03 Lion Corp Deodorant
JPH01317443A (ja) * 1988-06-16 1989-12-22 Nippon Zeon Co Ltd 脱臭性組成物
JPH02277456A (ja) * 1989-01-25 1990-11-14 Rikomu:Kk 消臭剤
JPH0538358A (ja) * 1991-08-07 1993-02-19 Rikomu:Kk 消臭剤

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4833035A (fr) * 1971-08-27 1973-05-07
JPS5036649A (fr) * 1973-08-06 1975-04-05
JPS6368172A (ja) * 1986-09-11 1988-03-28 松下電工株式会社 消臭剤
JPS6434368A (en) * 1987-07-31 1989-02-03 Lion Corp Deodorant
JPH01317443A (ja) * 1988-06-16 1989-12-22 Nippon Zeon Co Ltd 脱臭性組成物
JPH02277456A (ja) * 1989-01-25 1990-11-14 Rikomu:Kk 消臭剤
JPH0538358A (ja) * 1991-08-07 1993-02-19 Rikomu:Kk 消臭剤

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047045A1 (fr) * 1999-02-13 2000-08-17 Zylepsis Limited Composes et compositions de conservation
JP2009161502A (ja) * 2008-01-10 2009-07-23 Rikomu:Kk 腸内菌叢改善剤及び食品
US8945596B2 (en) 2008-10-20 2015-02-03 Conopco, Inc. Antimicrobial composition
US9132103B2 (en) 2009-09-24 2015-09-15 Conopco, Inc. Disinfecting agent comprising eugenol, terpineol and thymol
US9408870B2 (en) 2010-12-07 2016-08-09 Conopco, Inc. Oral care composition
US9693941B2 (en) 2011-11-03 2017-07-04 Conopco, Inc. Liquid personal wash composition
WO2013083585A1 (fr) 2011-12-06 2013-06-13 Unilever N.V. Composition antimicrobienne
WO2013092427A2 (fr) 2011-12-22 2013-06-27 Unilever N.V. Procédé et composition antimicrobiens
WO2013092427A3 (fr) * 2011-12-22 2013-08-15 Unilever N.V. Procédé et composition antimicrobiens

Also Published As

Publication number Publication date
AU2178897A (en) 1998-10-30
TW371630B (en) 1999-10-11

Similar Documents

Publication Publication Date Title
Hoskins The occurrence, metabolism and toxicity of cinnamic acid and related compounds
Lee et al. Essential oils in broiler nutrition
Tricker et al. Secondary amine precursors to nitrosamines in human saliva, gastric juice, blood, urine and faeces
KR101614963B1 (ko) 약산성하의 소취 조성물
WO1998044959A1 (fr) Composition desodorisante
BR112017000068B1 (pt) Composição eliminadora de maus odores e produto final
WO2006032668A1 (fr) Utilisation de mélanges de substances aromatiques comme agents contre la mauvaise haleine
US20220323372A1 (en) Composition for improving liver function
JP2002159566A (ja) 消臭剤及び抗菌剤
Parkash et al. Metabolism and excretion of [14C] furfural in the rat and mouse
WO2010073988A1 (fr) Composition de gomme à mâcher
JP2003335647A (ja) 消臭剤及びそれを含有する飲食品並びに消臭組成物
JP5742634B2 (ja) 新規ヒドロキシスチルベン誘導体
JPH01265964A (ja) 消臭剤
Würsch et al. Metabolism of L-sorbose in the rat and the effect of the intestinal microflora on its utilization both in the rat and in the human
JP5742589B2 (ja) 新規ヒドロキシスチルベン誘導体
JP5853546B2 (ja) 新規ヒドロキシスチルベン誘導体
JP5673025B2 (ja) 新規レスベラトロール誘導体
AU718850B2 (en) Deodorizing substance
JP2011020936A (ja) 口臭除去剤
JPH0538358A (ja) 消臭剤
WO2000064453A1 (fr) Desodorisants contre les odeurs de sulfures de fermentation intestinale
CN110603029A (zh) 香料原料和食品原料中有机过氧化物的减少
JPH04117326A (ja) 経口消臭剤
US20230330053A1 (en) Method for treating infections

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 2000572575

Format of ref document f/p: F